Cargando…

Solvents to Fragments to Drugs: MD Applications in Drug Design

Simulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Defelipe, Lucas A., Arcon, Juan Pablo, Modenutti, Carlos P., Marti, Marcelo A., Turjanski, Adrián G., Barril, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321499/
https://www.ncbi.nlm.nih.gov/pubmed/30544890
http://dx.doi.org/10.3390/molecules23123269
_version_ 1783385457068867584
author Defelipe, Lucas A.
Arcon, Juan Pablo
Modenutti, Carlos P.
Marti, Marcelo A.
Turjanski, Adrián G.
Barril, Xavier
author_facet Defelipe, Lucas A.
Arcon, Juan Pablo
Modenutti, Carlos P.
Marti, Marcelo A.
Turjanski, Adrián G.
Barril, Xavier
author_sort Defelipe, Lucas A.
collection PubMed
description Simulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and binding free energy predictions. The simulation of proteins in their condensed state reveals solvent structures and preferential interaction sites (hot spots) on the protein surface. The information provided by water and its cosolvents can be used very effectively to understand protein ligand recognition and to improve the predictive capability of well-established methods such as molecular docking. The application of MD simulations to the study of the association of proteins with drug-like compounds is currently only possible for specific cases, as it remains computationally very expensive and labor intensive. MDmix simulations on the other hand, can be used systematically to address some of the common tasks in SBDD. With the advent of new tools and faster computers we expect to see an increase in the application of mixed solvent MD simulations to a plethora of protein targets to identify new drug candidates.
format Online
Article
Text
id pubmed-6321499
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63214992019-01-14 Solvents to Fragments to Drugs: MD Applications in Drug Design Defelipe, Lucas A. Arcon, Juan Pablo Modenutti, Carlos P. Marti, Marcelo A. Turjanski, Adrián G. Barril, Xavier Molecules Review Simulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and binding free energy predictions. The simulation of proteins in their condensed state reveals solvent structures and preferential interaction sites (hot spots) on the protein surface. The information provided by water and its cosolvents can be used very effectively to understand protein ligand recognition and to improve the predictive capability of well-established methods such as molecular docking. The application of MD simulations to the study of the association of proteins with drug-like compounds is currently only possible for specific cases, as it remains computationally very expensive and labor intensive. MDmix simulations on the other hand, can be used systematically to address some of the common tasks in SBDD. With the advent of new tools and faster computers we expect to see an increase in the application of mixed solvent MD simulations to a plethora of protein targets to identify new drug candidates. MDPI 2018-12-11 /pmc/articles/PMC6321499/ /pubmed/30544890 http://dx.doi.org/10.3390/molecules23123269 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Defelipe, Lucas A.
Arcon, Juan Pablo
Modenutti, Carlos P.
Marti, Marcelo A.
Turjanski, Adrián G.
Barril, Xavier
Solvents to Fragments to Drugs: MD Applications in Drug Design
title Solvents to Fragments to Drugs: MD Applications in Drug Design
title_full Solvents to Fragments to Drugs: MD Applications in Drug Design
title_fullStr Solvents to Fragments to Drugs: MD Applications in Drug Design
title_full_unstemmed Solvents to Fragments to Drugs: MD Applications in Drug Design
title_short Solvents to Fragments to Drugs: MD Applications in Drug Design
title_sort solvents to fragments to drugs: md applications in drug design
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321499/
https://www.ncbi.nlm.nih.gov/pubmed/30544890
http://dx.doi.org/10.3390/molecules23123269
work_keys_str_mv AT defelipelucasa solventstofragmentstodrugsmdapplicationsindrugdesign
AT arconjuanpablo solventstofragmentstodrugsmdapplicationsindrugdesign
AT modenutticarlosp solventstofragmentstodrugsmdapplicationsindrugdesign
AT martimarceloa solventstofragmentstodrugsmdapplicationsindrugdesign
AT turjanskiadriang solventstofragmentstodrugsmdapplicationsindrugdesign
AT barrilxavier solventstofragmentstodrugsmdapplicationsindrugdesign